Featured Education

On Demand Activities

Therapeutics Areas
Learner Specialties
Expires After
Time Well Spent: Treating Obesity and Diabetes
Community Collective: Time Well Spent – Navigating the Challenges of Treating Obesity and Diabetes is an educational curriculum designed for rural primary care clinicians to enhance outcomes for individuals with obesity through improved diagnosis and use of therapy options to treat type 2 diabetes (T2D).
DIABESITY DIALOGUES: Patient Perspectives for PCPs - Tackling the Treatment Paradigms of Obesity, T2D, and Other Metabolic Disorders
There is an urgent need for effective intervention by healthcare professionals (HCPs) to address the twin epidemics of Type 2 diabetes (T2D) and obesity. Tune into the Diabesity Dialogues vodcast, where renowned physicians, Dr. Robert Kushner, MD, and Dr. Jamy Ard, MD, provide valuable insights on treatment initiation, intensification, and the effective management of diabesity in the presence of other comorbidities. Hear how our esteemed hosts harness the power of social media and discuss the latest information on GLP-1 receptor agonists (RA) and dual GIP/GLP-1 RAs and dispel potential misinformation. In this special feature, tune into patient voices from social media and learn practical tips to enhance patient-centered care and be at the forefront of transformative practices. Don’t miss this opportunity to join this cutting-edge conversation.
Advances in Non-Hodgkin Lymphoma Care: Navigating New and Emerging Treatments
In this first episode, “Making the Right Selection: Expert Guidance on Treatment Sequencing of T-cell Mediated Therapies,” from the 4-part series Med Table Talk, “The Power of the Community: Translating Innovations into Care in NHL and HL,” learn from expert faculty about unmet needs for patients with NHL based on an understanding of disease- and patient-related characteristics. Additionally, learn how to best assess eligible patients among new and emerging CAR T-cell and bispecific antibody therapies. Expert faculty will also discuss both the mechanisms of action of CAR T-cell and bispecific antibodies. This episode will conclude with a patient case study, which will consist of a dialogue between faculty.
Integrating Novel Therapies in Hemophilia in the Midst of Bridging Health Inequities
As the treatment armamentarium for patients with hemophilia continues to expand, there is an urgent need for healthcare providers to stay up-to-date on the latest advances so that they are prepared to integrate them into clinical practice. To bridge this gap, this interactive educational activity will provide a review of the science surrounding new and emerging hemophilia treatments and their mechanisms of action; recent safety and efficacy data from key clinical trials; and novel dosing strategies to mitigate adverse events. Engaging case-based discussions and insights on addressing common patient barriers and clinical challenges will be explored by expert faculty, including a guest spotlight offering the early perspective.  Thus, this educational initiative is designed to equip providers with the necessary tools to effectively navigate new and novel therapies, overcome patient-level barriers, and optimize adherence for improved patient outcomes.
Pacing the Continuum of Follicular Lymphoma: Integrating Prognostic Tools and Novel Treatment Approaches
New and emerging advancements in the treatment of follicular lymphoma (FL) are on the horizon. Are you and your clinical teams up for the challenge of testing your skill in applying the latest clinical evidence to these groundbreaking therapies? This independent satellite symposium is an engaging learning experience, where you’ll have the chance to compete against your colleagues in complex clinical cases of follicular lymphoma.
Build Your Own Case Study | From Evidence to Practice: Enhancing T2D Outcomes with Informed Approaches on Obesity
The tie between type 2 diabetes (T2D) and overweight/obesity is a significant global public health issue, supported by decades of extensive research. Despite formal clinical guidelines recommendations in addressing both diseases, the initiation or intensification of therapies that improve glycemic control and achieve weight reduction targets are slowly adopted into clinical practice, particularly for patients with T2D. Given the overlap of these two conditions, it is imperative that healthcare providers worldwide align clinical practice with evidence-based guidelines and the latest clinical findings using newer agents to treat both diseases.
Scroll to Top